Biomerica files for FDA Emergency Use Authorization (EUA) of its Unique Laboratory Antibody Test for COVID-19

NEXT STORY
Highly Accomplished Executives Join BioVie’s Board of Directors
PREV STORY
Sanofi’s investigational enzyme replacement therapy shows clinically meaningful improvement in critical manifestations of late-onset Pompe disease
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners

author_avatar
NASDAQ Market News

BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Small Cell Lung Cancer

author_avatar
NASDAQ Market News

At 15.6% CAGR, Global Cold Plasma Market Size Will Grow to USD 4.10 Billion By 2026: Facts & Factors

author_avatar
NASDAQ Market News